Nhật Bản chính thức phê duyệt vắcxin Pfizer/BioNTech

Theo Kyodo 22:13 14/02/2021

Ngày 14/2, Bộ Y tế, Lao động và Phúc lợi Nhật Bản đã thông báo chính thức cấp phép sử dụng vắcxin ngừa bệnh COVID-19 do hãng dược phẩm Pfizer của Mỹ kết hợp BioNTech của Đức sản xuất. Đây là vắcxin ngừa COVID-19 đầu tiên được Nhật Bản cấp phép sử dụng trong nước.

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